QQ客服 官方微博 反馈留言

	Randomized Comparisons of Double-Dose Clopidogrel or Adjunctive Cilostazol versus Standard Dual Anti-platelet in Patients with High Post-Treatment Platelet Reactivity: Results of the CREATIVE Trial (Clopidogrel Response Evaluation and AnTi-platelet Inter
	Tang Yi-Da; Wang Wenyao; Yang Min; Zhang Kuo; Chen Jing; Qiao Shubin; Yan Hongbing; Wu Yongjian; Huang Xiaohong; Xu Bo
	2018
关键词	anti-platelet cilostazol high post-treatment platelet reactivity platelet function
ISSN号	1524-4539
DOI	10.1161/CIRCULATIONAHA.117.030190
URL标识	查看原文
收录类别	PUBMED
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/6360912
专题	中国医学科学院 北京协和医学院
推荐引用方式 GB/T 7714	Tang Yi-Da,Wang Wenyao,Yang Min,et al. Randomized Comparisons of Double-Dose Clopidogrel or Adjunctive Cilostazol versus Standard Dual Anti-platelet in Patients with High Post-Treatment Platelet Reactivity: Results of the CREATIVE Trial (Clopidogrel Response Evaluation and AnTi-platelet Inter[J],2018.
APA	Tang Yi-Da.,Wang Wenyao.,Yang Min.,Zhang Kuo.,Chen Jing.,...&Yang Yuejin.(2018).Randomized Comparisons of Double-Dose Clopidogrel or Adjunctive Cilostazol versus Standard Dual Anti-platelet in Patients with High Post-Treatment Platelet Reactivity: Results of the CREATIVE Trial (Clopidogrel Response Evaluation and AnTi-platelet Inter..
MLA	Tang Yi-Da,et al."Randomized Comparisons of Double-Dose Clopidogrel or Adjunctive Cilostazol versus Standard Dual Anti-platelet in Patients with High Post-Treatment Platelet Reactivity: Results of the CREATIVE Trial (Clopidogrel Response Evaluation and AnTi-platelet Inter".(2018).

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。